journal article·2013-09

Conjugation of the photosensitizer Chlorin e6 to pluronic F127 for enhanced cellular internalization for photodynamic therapy

Hyung Park, Kun Na

Biomaterials· Volume 34· Issue 28
Publisher page

Abstract

To improve the cellular internalization and tumor-specific targeting efficiency of a photosensitizer, Chlorin e6 (Ce6), was conjugated to Pluronic F127(®) (PF127) by esterification between the carboxylic groups of Ce6 and the two hydroxyl groups of PF127 (PCe6). After conjugation, two different PCe6 conjugates, PF127/Ce6 (PCe6-1) and Ce6/PF127/Ce6 (PCe6-2), were obtained and separated by hydrophobic interaction chromatography. In this study, PCe6-1 was employed because it has good solubility in aqueous media. The singlet oxygen generation (SOG) efficiency and fluorescence activity of PCe6-1 in aqueous media dramatically increased compared to free Ce6. Moreover, confocal imaging and fluorescence-activated cell sorting (FACS) analysis confirmed its enhanced internalization rate in mouse colon tumor (CT-26) cells. After light irradiation, the cellular phototoxicity of PCe6-1 against CT-26 was approximately 3 times higher than that of free Ce6 in vitro. Furthermore, PCe6-1 exhibited enhanced tumor-specific distribution and tumor growth inhibition after intravenous injection into tumor-bearing mice. These results suggest that PCe6-1 is a good candidate as a photosensitizer due to its high cellular internalization rate and tumor targeting efficiency.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Porphyrin and Phthalocyanine Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (46)

Show source-provided references
1. Photodynamic therapy10.1093/jnci/90.12.889 ↗
2. Photodynamic therapy for cancer10.1038/nrc1071 ↗
3. How does photodynamic therapy work?10.1111/j.1751-1097.1992.tb04222.x ↗
4. Photodynamic therapy (PDT) for lung cancers10.1016/S1556-0864(15)31616-6 ↗
5. A nano complex of hydrophilic phthalocyanine and polyethylenimine for improved cellular internalization efficiency and phototoxicity10.1016/j.colsurfb.2012.06.036 ↗
6. Novel photosensitizer-protein nanoparticles for photodynamic therapy: photophysical characterization and in vitro investigations10.1016/j.jphotobiol.2009.04.006 ↗
7. Nanoparticles as vehicles for delivery of photodynamic therapy agents10.1016/j.tibtech.2008.07.007 ↗
8. Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system10.1016/j.biomaterials.2011.02.009 ↗
9. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy10.1039/cs9952400019 ↗
10. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs10.1016/j.addr.2003.12.004 ↗
11. Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizer10.1016/j.biomaterials.2013.01.010 ↗
12. Photodynamic efficacy of photosensitizers under an attenuated light dose via lipid nano-carrier-mediated nuclear targeting10.1016/j.biomaterials.2012.04.023 ↗
13. Liposomes for photodynamic therapy10.1016/j.addr.2003.07.014 ↗
14. Pegylation of a chlorine6 polymer conjugate increases tumor targeting of photosensitizer
15. Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity10.1016/j.biomaterials.2005.05.028 ↗
16. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release10.1016/j.jconrel.2006.07.011 ↗
17. Self-assembled hydrogel nanoparticles responsive to tumor extracellular pH from pullulan derivative/sulfonamide conjugate: characterization, aggregation, and adriamycin release in vitro10.1023/A:1015370532543 ↗
18. Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel10.1097/00001813-200104000-00003 ↗
19. The controlled photoactivity of nanoparticles derived from ionic interactions between a water soluble polymeric photosensitizer and polysaccharide quencher10.1016/j.biomaterials.2011.07.023 ↗
20. Oral drug absorption enhancement by chitosan and its derivatives10.1016/S0169-409X(01)00231-9 ↗
21. Experimental grounds for using chlorin e6 in the photodynamic therapy of malignant tumors10.1016/1011-1344(93)06974-8 ↗
22. High efficiency and low toxicity of polyethyleneimine modified pluronics (PEI-Pluronic) as gene delivery carriers in cell culture and dystrophic mdx mice10.1039/c2jm15625c ↗
23. Block copolymeric biotransport carriers as versatile vehicles for drug delivery10.1517/13543784.7.9.1453 ↗
24. Mechanism of sensitization of MDR cancer cells by pluronic block copolymers: selective energy depletion10.1054/bjoc.2001.2165 ↗
25. Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers10.1016/j.jconrel.2010.01.004 ↗
26. Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers10.1023/A:1011964213024 ↗
27. Design and formulation of polyplexes based on pluronic-polyethyleneimine conjugates for gene transfer10.1021/bc025504w ↗
28. Pluronic® block copolymers: novel functional molecules for gene therapy10.1016/S0169-409X(02)00018-2 ↗
29. Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery10.1016/S0168-3659(02)00009-3 ↗
30. Pluronic® block copolymers for overcoming drug resistance in cancer10.1016/S0169-409X(02)00047-9 ↗
31. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers10.1016/j.jconrel.2008.04.013 ↗
32. In vitro and in vivo efficacy of Photofrin® and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells10.1562/0031-8655(2002)075<0140:IVAIVE>2.0.CO;2 ↗
33. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects10.1021/bc100070g ↗
34. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer10.1021/ja801631c ↗
35. Self-quenching polysaccharide-based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy10.1016/j.biomaterials.2010.04.030 ↗
36. Determination of the singlet oxygen quantum yield of bacteriochlorin a: a comparative study in phosphate buffer and aqueous dispersion of dimiristoyl-L-α-phosphatidylcholine liposomes10.1039/b201081j ↗
37. Singlet oxygen generation by photodynamic agents10.1016/S1011-1344(96)07349-6 ↗
38. Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice10.1016/j.biomaterials.2009.01.058 ↗
39. Drug release characteristics of PAMAM dendrimer–drug conjugates with different linkers10.1016/j.ijpharm.2009.10.017 ↗
40. Synthesis, cellular transport, and activity of polyamidoamine dendrimer-methylprednisolone conjugates10.1021/bc0498018 ↗
41. Mechanisms of micellization and rheology of PEO–PPO–PEO triblock copolymers with various architectures10.1016/j.jcis.2008.09.029 ↗
42. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications10.1016/j.biomaterials.2009.06.004 ↗
43. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system10.1016/S0378-5173(99)00447-0 ↗
44. Critical importance of the triplet lifetime of photosensitizer in photodynamic therapy of tumor10.1111/j.1751-1097.1989.tb04167.x ↗
45. An apoptotic response to photodynamic therapy with endogenous protoporphyrin in vivo10.1016/S1011-1344(96)07291-0 ↗
46. Targeted nanodelivery of drugs and diagnostics10.1016/j.nantod.2010.03.003 ↗